MTF Biologics, a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, and Kolosis BIO (Kolosis), a premier provider of ...

As previously disclosed, in late Q3 2022, the Company began to experience material supply issues related to its ALLOCYTE ® Advanced Cellular Bone Matrix (“ALLOCYTE”) product line. The supply ...

In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...

The utilization of biodegradable biomaterials as a therapeutic modality for musculoskeletal tissue regeneration has emerged as a promising avenue for ...

A recent discovery could transform our understanding of bone health maintenance and pave the way for potential treatments for bone diseases, including osteoporosis. Researchers at the University of ...

In a recent study from Institute of Science Tokyo, Japan, researchers showed that microRNAs (miRNAs), small, non-coding RNA sequences, can stimulate Wnt signaling and bone morphogenetic protein ...

Bone defects are a major challenge in regenerative medicine, often requiring advanced biomaterials to enhance the natural healing process. Traditional bone repair methods, including bone grafts, face ...